Tenpoint Therapeutics
Vision Restoration for Presbyopia, Cataracts, and Geographic Atrophy | Tenpoint Therapeutics™
Irvine · Founded 2019 · $155.0M raised
- Headquarters
- Irvine, California
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- tenpointtherapeutics.com
- Total Funding
- $155.0M
- Last Round
- $85.0M Series BJan 2026
- Rounds
- 2
About
Tenpoint Therapeutics is a global clinical-stage biotech company developing regenerative medicines to restore vision in aging eyes. Its pipeline targets presbyopia, cataracts, and geographic atrophy, with lead candidate YUVEZZI for age-related lens conditions. The company was founded in 2019 and operates across the United States and United Kingdom.
Summary
Tenpoint Therapeutics is a Biotech company based in Irvine, founded in 2019. It has raised $155.0M in total across 2 rounds, most recently a $85.0M Series B round in Jan 2026. Investors include F-Prime Capital and Sofinnova Partners.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...